GlaxoSmithKline (GSK) Consumer Healthcare has launched the first salvo of its $150 million effort for Alli, the first FDA-approved over-the-counter weight loss drug in years. The effort for Alli ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results